Research Topics
| Gemma GattaSummaryAffiliation: Istituto Nazionale Tumori Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Childhood cancer survival trends in Europe: a EUROCARE Working Group studyGemma Gatta
Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milano, Italy
J Clin Oncol 23:3742-51. 2005..EUROCARE collected data from population-based cancer registries in 20 European countries. We used this data to compare childhood cancer survival time trends in Europe...
Patterns of care for European colorectal cancer patients diagnosed 1996-1998: a EUROCARE high resolution studyGemma Gatta
Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Acta Oncol 49:776-83. 2010....
The burden of rare cancers in EuropeGemma Gatta
Fondazione IRCCS Istituto Nazionale dei Tumori, Dipartimento di Medicina Predittiva e per la Prevenzione, Unità di Epidemiologia Valutativa, Via Venezian, 1, 20133, Milan, Italy
Adv Exp Med Biol 686:285-303. 2010..The burden indicators were estimated and are provided in this chapter...
Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002Gemma Gatta
Haematologica 98:744-52. 2013..Nevertheless, a small excess risk of death persisted beyond five years after diagnosis when patients remained at risk for late treatment effects, late relapses and second primaries...
Embryonal cancers in EuropeGemma Gatta
Department of Preventive and Predictive Medicine, Fondazione IRCSS, Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
Eur J Cancer 48:1425-33. 2012..Survival/cure rate is generally high, but there are considerable gaps in our understanding of the natural histories of these rare diseases particularly in adults...
Survival for ethmoid sinus adenocarcinoma in European populationsGemma Gatta
Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, Milan, Italy
Acta Oncol 48:992-8. 2009..Adenocarcinoma of the ethmoid sinus is rare. EUROCARE data provide a good opportunity to study the survival of this rare disease in a population of continental size...
Late outcomes of colorectal cancer treatment: a FECS-EUROCARE studyGemma Gatta
Epidemiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy
J Cancer Surviv 1:247-54. 2007....
Rare cancers are not so rare: the rare cancer burden in EuropeGemma Gatta
Department of Preventive and Predictive Medicine, Fondazione IRCSS, Istituto Nazionale dei Tumori, Via Venezian 1, Milan, Italy
Eur J Cancer 47:2493-511. 2011..The project Surveillance of Rare Cancers in Europe (RARECARE) provides estimates of the incidence, prevalence and survival of rare cancers in Europe based on a new and comprehensive list of these diseases...
Prostate cancer treatment in Europe at the end of 1990sGemma Gatta
Evaluative Epidemiology Unit, Fondazione IRCCS, Istituto Nazionale Tumori, Milan, Italy
Acta Oncol 48:867-73. 2009..We therefore aimed to characterize treatment for prostate cancer across Europe...
Survival from rare cancer in adults: a population-based studyGemma Gatta
Epidemiology Unit, National Cancer Institute, Milan, Italy
Lancet Oncol 7:132-40. 2006..We aimed to study the epidemiology of rare cancers in a large population of several countries...
Rectal cancerMaria Giulia Zampino
Medical Care Unit, European Institute of Oncology, Milan, Italy
Crit Rev Oncol Hematol 70:160-82. 2009..Updated recommendations for the management of these patients are here reported...
Survival of European children and young adults with cancer diagnosed 1995-2002Gemma Gatta
Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
Eur J Cancer 45:992-1005. 2009..Cancer survival in patients <25 years is poorly documented in Eastern European countries. Complete cancer registration should be a priority for these countries as an essential part of a policy for effective cancer control in Europe...
The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) projectAnnalisa Trama
Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, Italy
Tumori 98:550-8. 2012....
Human papillomavirus in HNSCC: a European epidemiologic perspectiveLisa Licitra
Head and Neck Medical Oncology Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
Hematol Oncol Clin North Am 22:1143-53, vii-viii. 2008..Three-year survival rates improved more in human papillomavirus-related than unrelated cancer sites, and women had better rates of survival than men...
Survival from salivary glands adenoid cystic carcinoma in European populationsLaura Ciccolallo
Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, Italy
Oral Oncol 45:669-74. 2009..Improvements in the disease detection in its early stage and international collaborative research should be encouraged...
Major and minor salivary gland tumorsMarco Guzzo
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Crit Rev Oncol Hematol 74:134-48. 2010..Metastatic disease may be either treated with radiotherapy or palliative chemotherapy, depending on the site of metastases. For highly selected patients the employment of anti-androgen therapy is indicated...
Childhood cancer survival in Europe and the United StatesGemma Gatta
Division of Epidemiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Cancer 95:1767-72. 2002..The objective of this study was to determine whether transatlantic differences in survival also are present in childhood cancers...
EpendymomaMichele Reni
Medical Oncology Unit, San Raffaele Scientific Institute, Milan, Italy
Crit Rev Oncol Hematol 63:81-9. 2007..There is no proof that postoperative chemotherapy improves the outcome. At recurrence, platinum-, nitrosourea- or temozolomide-based chemotherapy can be administered, although there is no evidence of efficacy...
Rectal cancerMaria Giulia Zampino
European Institute of Oncology, Milan, Italy
Crit Rev Oncol Hematol 51:121-43. 2004..Updated recommendations for the management of these patients are here reported...
[Case-control evaluation of screening efficacy]Franco Berrino
, Dipartimento di medicina preventiva e predittiva, Istituto Nazionale per lo Studio e la Cura dei Tumori di Milano
Epidemiol Prev 28:354-9. 2004
Childhood medulloblastomaMaura Massimino
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Crit Rev Oncol Hematol 79:65-83. 2011....
Cancer of the larynxLisa Licitra
START Project, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Crit Rev Oncol Hematol 47:65-80. 2003..The loco-regional extent of the disease determines the success of cure. Surgery and radiotherapy represent the main therapeutic options. The choice between these two procedures is often controversial...
Ovarian cancerNicoletta Colombo
European Institute of Oncology, Division of Gynecology, Via Ripamonti 435, Milan, Italy
Crit Rev Oncol Hematol 60:159-79. 2006..Salvage chemotherapy in platinum-refractory patients usually results in low response rates and short survival...
Cancer of the nasopharynxLisa Licitra
START Project and Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Crit Rev Oncol Hematol 45:199-213. 2003..Standard therapeutic option for early stages of NPC is radiation, while an integration of radiation therapy and chemotherapy is indicated in more advanced stages...
International collaborations in cancer control and the Third International Cancer Control CongressAndrea Micheli
Descriptive Studies and Health Planning Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
Tumori 95:579-96. 2009..As a consequence, less resources of development aids are allocated to control NCDs including cancer...
Cancer of pancreasFilippo De Braud
START Project and European Institute of Oncology, Milan, Italy
Crit Rev Oncol Hematol 50:147-55. 2004..Radical surgery is indicated for patients with early stage of disease, mainly stage I and partially II. In all other cases, the aim of treatment is the palliation of different very distressing symptoms related to this neoplasm...
Regional estimates of prostate cancer burden in ItalyRiccardo Inghelmann
Reparto di Epidemiologia dei Tumori, Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della Salute, Istituto Superiore di Sanita, Rome, Italy
Tumori 93:380-6. 2007....
Explaining gastric cancer survival differences among European countriesArduino Verdecchia
Laboratory of Epidemiology and Biostatistics, Istituto Superiore di Sanita, Viale Regina Elena 299, 00161 Rome, Italy
Int J Cancer 109:737-41. 2004..There is a need to improve completeness and standardization of detailed information collected on gastric cancer patients to allow detailed comparative analyses and interpretation...
Incidence of uveal melanoma in EuropeGianni Virgili
Department of Ophthalmology, University of Florence, Florence, Italy
Ophthalmology 114:2309-15. 2007..To estimate incidence rates of uveal melanoma in Europe from 1983 to 1994...
Cancer survival in five continents: a worldwide population-based study (CONCORD)Michel P Coleman
Cancer Research UK Cancer Survival Group, Non communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, London, UK
Lancet Oncol 9:730-56. 2008..This is, to our knowledge, the first worldwide analysis of cancer survival, with standard quality-control procedures and identical analytic methods for all datasets...
Incidence of and survival from Wilms' tumour in adults in Europe: data from the EUROCARE studyEmmanuel Mitry
, Centre Hospitalo-Universitaire Ambroise Par, AP-HP, , 92100 Boulogne, France
Eur J Cancer 42:2363-8. 2006..This may, at least partly, be explained by the rarity of this diagnosis. Prognosis may be improved by the use of specific treatment guidelines for nephroblastoma in adults...
Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 dataArduino Verdecchia
National Centre for Epidemiology, Health Surveillance and Promotion, Istituto Superiore di Sanita, Rome, Italy
Lancet Oncol 8:784-96. 2007..We also compared our findings with data on cancer survival in the USA from the US SEER (Surveillance, Epidemiology, and End Results) programme...
Survival in patients with uveal melanoma in EuropeGianni Virgili
Department of Oto Neuro Ophthalmological Surgical Sciences, University of Florence, Viale Morgagni 85, Florence 50134, Italy
Arch Ophthalmol 126:1413-8. 2008..To estimate survival in patients in whom uveal melanoma was diagnosed between January 1, 1983, and December 31, 1994, in Europe...
Renal cancerEnrichetta Corgna
Ospedale Silvestrini, Azienda Ospedaliera di Perugia, Italy
Crit Rev Oncol Hematol 64:247-62. 2007..Biologic agents represent the major effective therapies for widespread metastatic renal cancer. An antiangiogenic strategy, the neutralization of VEGF, can slow the growth rate of advanced cancer...
OligodendrogliomaMartin J van den Bent
Daniel den Hoed Cancer Clinic Erasmus University Medical Center, Rotterdam, The Netherlands
Crit Rev Oncol Hematol 66:262-72. 2008..Adjuvant PCV chemotherapy increased progression-free survival but does not improve survival as compared to PCV given at recurrence. Chemotherapy with either PCV or temozolomide constitutes a standard for recurrent/progressive disease...
Glioblastoma in adultsAlba A Brandes
Department of Medical Oncology, Bellaria Maggiore Hospital, Azienda ASL, Bologna, Italy
Crit Rev Oncol Hematol 67:139-52. 2008..At time of recurrence/progression, a nitrosourea-based chemotherapy constitutes a reasonable option, as well as a temozolomide re-challenge for patients without progression during prior temozolomide treatment...
Cancer of the prostateSergio Bracarda
Ospedale Silvestrini, Azienda Ospedaliera di Perugia, Italy
Crit Rev Oncol Hematol 56:379-96. 2005..5 months) and quality of life with docetaxel in more than 1,600 cases...
Adult acute lymphoblastic leukaemiaRenato Bassan
Ospedali Riuniti, Bergamo, Italy
Crit Rev Oncol Hematol 50:223-61. 2004..Therapeutic progress may be obtainable through a careful integration of chemotherapy, stem cell transplantation, and the new targeted treatments with highly specific metabolic inhibitors and humanised monoclonal antibodies...
Anaplastic astrocytoma in adultsRoger Stupp
University Hospital CHUV, Lausanne, Switzerland
Crit Rev Oncol Hematol 63:72-80. 2007..In recurrent disease, chemotherapy with temozolomide has been proven to be active and well-tolerated in phase II trials, but no comparative phase III trials of other cytotoxic drugs have been conducted...
Colon cancerRoberto Labianca
Ospedali Riuniti, Bergamo, Italy
Crit Rev Oncol Hematol 51:145-70. 2004..This report summarizes the most important achievements in this field and provides the readers useful suggestions for their professional practice...
Adult acute myeloid leukaemiaMatthew Smith
St Bartholomew's Hospital, London, UK
Crit Rev Oncol Hematol 50:197-222. 2004....
